MAPT and Alzheimer disease: Proposals to extend the AT(N) framework (to classify Alzheimer's disease on the basis of biomarkers of amyloid-β [A], tau [T] and neurodegeneration [N]) to an ATX(N) system (where X represents biomarkers of other pathological mechanisms) integrating additional mechanisms move towards acknowledging and incorporating this complexity.37